Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
144.18
3.78 (2.69%)
At close: Sep 05, 2025, 3:59 PM
141.96
-1.54%
After-hours: Sep 05, 2025, 06:07 PM EDT
Neurocrine Biosciences Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue Revenue | 5.5M | 8.9M | 6.5M | 5.5M | 6.4M | 6.3M | 8M | 7M | 6.4M | 5.1M | 7.4M | 8.6M | 26.2M | 5.6M | 8.5M | 7.2M | 22.1M | 5.6M | 6.6M | 4.4M | 34.8M | 6M | 6.18M | 24M | 3.04M | 1.97M | 1.17M | 40.47M |
| Collaboration Revenue Revenue Growth | -38.20% | +36.92% | +18.18% | -14.06% | +1.59% | -21.25% | +14.29% | +9.38% | +25.49% | -31.08% | -13.95% | -67.18% | +367.86% | -34.12% | +18.06% | -67.42% | +294.64% | -15.15% | +50.00% | -87.36% | +480.00% | -2.90% | -74.25% | +690.51% | +53.96% | +69.13% | -97.12% | n/a |
| Product Revenue | 682M | 563.7M | 621.2M | 616.6M | 583.8M | 509M | 507.2M | 491.8M | 446.3M | 415.3M | 404.6M | 379.3M | 352M | 305M | 303.5M | 288.8M | n/a | 231M | 241.3M | 254.1M | 267.6M | 231.1M | 237.83M | 198.09M | 180.54M | 136.43M | 130.33M | 111.29M |
| Product Revenue Growth | +20.99% | -9.26% | +0.75% | +5.62% | +14.70% | +0.35% | +3.13% | +10.19% | +7.46% | +2.64% | +6.67% | +7.76% | +15.41% | +0.49% | +5.09% | n/a | n/a | -4.27% | -5.04% | -5.04% | +15.79% | -2.83% | +20.06% | +9.72% | +32.33% | +4.68% | +17.10% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 286.3M | 276.5M | 287.8M | 234.3M | 242M | 243.1M | 218.9M | 204.2M | 221.8M | 242.7M | 182.9M | 186.3M | 182.8M | 200.7M | 156.5M | 154.6M | 143.2M | 129M | 106.5M | 112.5M | 96.5M | 117.8M | 101.3M | 84.49M | 80.82M | 87.54M | 68.98M | 60.4M | 60.91M | 58.64M | 56.31M | 43.87M | 41.67M | 28.05M | 23.67M | 17.49M | 14.96M | 11.95M | 8.94M | 11.46M | 6.6M | 5.48M |
| Selling, General, and Administrative Revenue Growth | +3.54% | -3.93% | +22.83% | -3.18% | -0.45% | +11.06% | +7.20% | -7.94% | -8.61% | +32.70% | -1.83% | +1.91% | -8.92% | +28.24% | +1.23% | +7.96% | +11.01% | +21.13% | -5.33% | +16.58% | -18.08% | +16.29% | +19.90% | +4.53% | -7.67% | +26.90% | +14.20% | -0.84% | +3.89% | +4.13% | +28.35% | +5.28% | +48.57% | +18.51% | +35.29% | +16.90% | +25.19% | +33.73% | -21.97% | +73.50% | +20.45% | n/a |
| Research and Development Revenue | 244.3M | 263.2M | 185.6M | 195M | 191.1M | 159.4M | 137.5M | 142.2M | 145.8M | 139.5M | 118M | 107.7M | 135.9M | 102.2M | 87.4M | 92.7M | 74.8M | 73.2M | 66.7M | 69.1M | 80.9M | 58.3M | 55.42M | 45.3M | 61.7M | 37.7M | 39.11M | 35.48M | 36.99M | 48.95M | 25.61M | 22.46M | 21.87M | 51.88M | 22.58M | 20.94M | 26.86M | 23.9M | 21.81M | 24.39M | 18.72M | 16.57M |
| Research and Development Revenue Growth | -7.18% | +41.81% | -4.82% | +2.04% | +19.89% | +15.93% | -3.31% | -2.47% | +4.52% | +18.22% | +9.56% | -20.75% | +32.97% | +16.93% | -5.72% | +23.93% | +2.19% | +9.75% | -3.47% | -14.59% | +38.77% | +5.19% | +22.35% | -26.58% | +63.66% | -3.60% | +10.22% | -4.07% | -24.43% | +91.09% | +14.03% | +2.72% | -57.85% | +129.74% | +7.84% | -22.04% | +12.38% | +9.60% | -10.57% | +30.28% | +12.94% | n/a |